Formulation: current opportunities and what’s next?
Supported by:
18 September 2024
2:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
During this virtual panel, industry experts will explore the latest innovations and major challenges of drug formulation in the pharmaceutical industry.
During this virtual panel, industry experts will explore the latest innovations and major challenges of drug formulation in the pharmaceutical industry. Pharmaceutical drug formulation encompasses combining drug substances and excipients to create drug products that meet the needs of patients, either in broad or personalised capacity. Formulation types include solid dose like conventional tablets and capsules, alongside powders and liquid formulations.
The field is complex and requires a multitude of approaches to overcome issues around efficiency and delivery, regulatory compliance, as well as patient adherence and more. For example, industry must also maintain awareness of and work to address risks such as nitrosamine impurities.
Formulators must consider administration methods such as parenteral and oral delivery and understand the unique considerations and challenges of each type. Furthermore, drug release profiles like long-acting or delayed release, present additional factors to work with during development.
Innovative techniques incorporating analytical methods such as chromatography can help the industry to find solutions to major bottlenecks. Meanwhile, formulation scientists must also tackle manufacturing challenges to enable scale-up, so utilising efficient procedures is important for future success.
In this session, speakers will share their insights and experiences on developing efficient and safe drug formulations. They will explore the latest advances, benefits offered by technology, plus approaches for overcoming critical and existing challenges.
Key learning points:
- Discover the latest advances being used by drug formulators in the pharmaceutical industry in 2024
- Learn about approaches that can support manufacturers, ensure optimal product quality and aid patient compliance
- Hear from industry experts and find out how to overcome key challenges in delivery, administration and drug development.
